Logo

Genome Therapeutics Delivers Data for Cancer Gene Identification

Jun 04, 1999
Premium

WALTHAM, Mass.--Genome Therapeutics has completed a sequencing contract for researchers from the Cancer Research Centre at Queen's University in Belfast, UK.

As part of the agreement, Genome Therapeutics sequenced several regions of the human genome for the institute. Using its proprietary sequencing methods, the biotech company created libraries for each clone, generated sequence reads that provided for greater than six-fold coverage of the region, and provided preliminary analysis of the sequenced regions.

Filed under

Informatics
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.